Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |